RANTES (Regulated upon Activation, Normal T cell Expressed and presumably Secreted) is a chemokine engaged in the pathophysiology of diabetes type 2 (T2DM), related cardiovascular complications, dyslipidemia and hypertension that are major modifiable risk factors of T2DM. VEGF (Vascular endothelial growth factor) plays a role in diabetic vascular complications.
(2023). RANTES as a Novel Biomarker for Atherogenic Dyslipidemia and Metabolic Disturbances in Patients with Type-2 Diabetes. Egyptian Society of Diabetes and Lipidology Journal, 3(2), -. doi: 10.21608/esdlj.2023.456210
MLA
. "RANTES as a Novel Biomarker for Atherogenic Dyslipidemia and Metabolic Disturbances in Patients with Type-2 Diabetes", Egyptian Society of Diabetes and Lipidology Journal, 3, 2, 2023, -. doi: 10.21608/esdlj.2023.456210
HARVARD
(2023). 'RANTES as a Novel Biomarker for Atherogenic Dyslipidemia and Metabolic Disturbances in Patients with Type-2 Diabetes', Egyptian Society of Diabetes and Lipidology Journal, 3(2), pp. -. doi: 10.21608/esdlj.2023.456210
VANCOUVER
RANTES as a Novel Biomarker for Atherogenic Dyslipidemia and Metabolic Disturbances in Patients with Type-2 Diabetes. Egyptian Society of Diabetes and Lipidology Journal, 2023; 3(2): -. doi: 10.21608/esdlj.2023.456210
)
